N-acetylcysteine administration during the first week of life does not improve lung function in extremely low birth weight infants

Biology of the Neonate

Volumn 86, Issue 4, 2004, Pages 275-279

  Sandberg, Kenneth ^a,d   Fellman, Vineta ^b,c   Stigson, Lennart ^a   Thiringer, Klara ^a   Hjalmarson, Ola ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

^c LUND UNIVERSITY   (Sweden)

^d QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

Antioxidant defense system; Bronchopulmonary dysplasia; Lung function testing; N acetylcysteine treatment; NAC treatment in preterm infants

Indexed keywords

ACETYLCYSTEINE; PLACEBO;

ARTICLE; BIRTH WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FUNCTIONAL RESIDUAL CAPACITY; GAS MIXING; GESTATIONAL AGE; HUMAN; INFANT; LOW BIRTH WEIGHT; LUNG COMPLIANCE; LUNG FUNCTION; LUNG INJURY; LUNG MECHANICS; LUNG RESISTANCE; MALE; MULTICENTER STUDY; NEWBORN; NEWBORN INTENSIVE CARE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYSTEM;

ACETYLCYSTEINE; BRONCHOPULMONARY DYSPLASIA; GLUTATHIONE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE, NEONATAL; LUNG; LUNG COMPLIANCE; PLACEBOS; RESPIRATORY FUNCTION TESTS;

EID: 8344247129     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080089     Document Type: Article

References (28)

1. Clark RH, Gertsmann DR, Jobe AH, Moffitt ST, Slutsky AS, Yoder BA: Lung injury in neonates: Causes, strategies for prevention, and long-term consequences. J Pediatr 2001;139:478-486.
2. Jobe AH, Bancalari E: Bronchopulmonary dysplasia. NICHD/NHLBI/ORD workshop summary. Am J Respir Crit Care Med 2001;163:1723-1729.
3. Saugstad OD: Oxygen toxicity in the neonatal period. Acta Paediatr Scand 1990;79:881-892.
4. Coalson JJ, Winter V, deLemos RA: Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia. Am J Respir Crit Care Med 1995;152:640-646.
5. Ogihara T, Okamoto R, Kim HS, Nagai A, Takao M, Moji H, Kamegai H, Hirano K, Ogihara H, Tamai H: New evidence for the involvement of oxygen radicals in triggering neonatal chronic lung disease. Pediatr Res 1996;39:117-119.
6. Husain AN, Siddiqui NH, Stocker JT: Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998;29:710-717.
7. Saldanha RL, Cepeda EE, Poland RL: The effect of vitamin E prophylaxis on the incidence and severity of bronchopulmonary dysplasia. J Pediatr 1982;101:89-93.
8. Shenai JP, Kennedy KA, Chytil F, Stahlman MT: Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr 1987;111:269-277.
9. Tyson JE, Wright LL, Oh W, Kennedy KA, Mele L, Ehrenkranz RA, Stoll BJ, Lemons JA, Stevenson DK, Bauer CR, Korones SB, Fanaroff AA: Vitamin A supplementation for extremely low birth weight infants. N Engl J Med 1999;340:1962-1968.
10. Rosenfeld WN, Davis JM, Parton L, Richter SE, Price A, Flaster E, Kassem N: Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 1996;97:811-817.
11. Jain A, Mehta T, Auld PA, Rodrigues J, Ward RF, Schwartz MK, Martensson J: Glutathione metabolism in newborns: Evidence for glutathione deficiency in plasma, bronchoalveolar lavage, and lymphocytes in prematures. Pediatr Pulmonol 1995;20:160-166.
12. Frank L, Sosenko IR: Prenatal development of lung antioxidant enzymes in four species. J Pediatr 1987;110:106-110.
13. Levonen AL, Lapatto R, Saksela M, Raivio KO: Expression of γ-glutamylcysteine synthetase during development. Pediatr Res 2000;47:266-270.
14. Vina J, Vento M, Garcia S, Puertes IR, Gasco E, Sastre J, Asensi M, Pallardo FV: L-Cysteine and glutathione metabolism are impaired in premature infants due to cystathionase deficiency. Am J Clin Nutr 1995;61:1067-1069.
15. Aruoma OI, Halliwell B, Hoey BM, Butler J: The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989;6:593-597.
16. Cotgreave I, Moldéus P, Schuppe I: The metabolism of N-acetylcysteine by human endothelial cells. Biochem Pharmacol 1991;42:13-16.
17. Flanagan RJ, Meredith TJ: Use of N-acetylcysteine in clinical toxicology. Am J Med 1991;91:131-139.
18. Ahola T, Lapatto R, Raivio KO, Selander BO, Stigson L, Jonsson B, Jonsbo F, Esberg G, Stövring S, Kjartansson S, Stiris T, Lossius K, Virkola K, Fellman V: N-acetylcysteine does not prevent bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr 2003;143:713-719.
19. LeSouëf PN, England SJ, Bryan AC: Passive respiratory mechanics in newborn infants and children. Am Rev Respir Dis 1984;129:552-556.
20. Sandberg K, Sjöqvist BA, Hjalmarson O, Olsson T: Analysis of alveolar ventilation in the newborn. Arch Dis Child 1984;59:542-547.
21. Becklake MR: A new index of the intrapulmonary mixture of inspired air. Thorax 1952;7:111-116.
22. Shao H, Sandberg K, Sjöqvist BA, Hjalmarson O: Moment analysis of multi-breath nitrogen washout in healthy preterm infants. Pediatr Pulmonol 1998;25:52-58.
23. Sjöqvist BA, Sandberg K, Hjalmarson O, Olsson T: Method for analyzing multiple-breath nitrogen washouts. Med Biol Eng Comput 1986;24:83-90.
24. Shao H, Sandberg K, Hjalmarson O: Impaired gas mixing and low lung volume in preterm infants with mild chronic lung disease. Pediatr Res 1998;43:536-541.
25. Ellsbury DL, Acarregui MJ, McGuinness GA, Klein JM: Variability in the use of supplemental oxygen for bronchopulmonary dysplasia. J Pediatr 2002;140:247-249.
26. Hjalmarson O, Sandberg K: Abnormal lung function in healthy preterm infants. Am J Respir Crit Care Med 2002;165:83-87.
27. Welty SE: Antioxidants and oxidation in bronchopulmonary dysplasia: There are no easy answers. J Pediatr 2003;143:697-698.
28. Ahola T, Fellman V, Kjellmer I, Raivio KO, Lapatto R: Plasma 8-isoprostane is increased in preterm infants who develop bronchopulmonary dysplasia or periventricular leukomalacia. Pediatr Res 2004;56:88-93.